Puna Bio logo
Puna Bio logo

Puna Bio

puna.bio
puna.bio • HQ: Buenos Aires, Argentina • Venture - Series Unknown 2025 • 51-200 employees • Founded 2020 • Startup
HQ: Buenos Aires, Argentina • Venture - Series Unknown 2025 • 51-200 employees • Founded 2020 • Startup
Health Care
Biologics & Biosimilars
Biotechnology
As featured in
Forbes Argentina
Nasdaq
YahooFinance
Claim pageClaim
Follow
Overview
News
Salaries
Products
People
Growth
Offices
Financials

Funding and backers

Total raised
$20.3M
1 round on record
Latest round
$20.3M
Venture round · Mar 2025 · 19 mo ago
Team
51-200
employees, estimated range
Backers
3
SOSV, At One Ventures
The money's age
Due for its next round
19 months since the last round · not hiring
Momentum
15/100
in the news
Last sign of life
1 mo ago
a posting or a news item
The story so fareach stage dated by its source: the company's releases, the press, registers, filings
Mar 5, 2025 Raised a round Venture round $20.3M · SEC Form D 2020 Founded
Tractionpublic signals, read monthly
Web presence
top 6%
of 133.2M domains by links, Common Crawl
Funding rounds
RoundDateAmountInvestorsSource
Venture round Mar 2025 $20.3M — SEC Form D
Registers and programsofficial lists and records that name the company
Legal entity Puna Bio Corp SEC Form D
Founders and leadersfrom filings, registers and the company's site
Franco LevisExecutive Officer, DirectorSEC Form D
Carolina BelfioreExecutive OfficerSEC Form D
Elisa BertiniExecutive Officer, DirectorSEC Form D
Maria FariasExecutive OfficerSEC Form D
Backed byfrom the funds' portfolios and accelerator catalogs
SOSV accelerator At One Ventures fund Dalus Capital fund
Investors in similar startupsfunds that back the companies most like this one
Techstars
backs Nunatak Biotech, Biolinco
Plug and Play
backs Core Biogenesis
Entrepreneur First
backs Core Biogenesis
TLV Partners
backs Immunai
SR One
backs Oruka Therapeutics
Perot Jain
backs Immunai
Similar startupsby what they do, their industry and backers
Nunatak Biotech11-50 employees
Next-generation biological solutions from extreme microbiomes to improve crop resilience, stress tolerance, and productivity in degraded…
Biolinco201-500 employees
High-throughput cell line development for biopharmaceuticals. DNA barcoding platform that screens thousands of CHO cell lines…
Oruka Therapeutics1-10 employees
Who We Are Our Pipeline Overview Presentations and Publications Join Us Investors Overview Press Releases Events & Presentations Stock…
Core BiogenesisFounded 2020
Core Biogenesis grows recombinant proteins and peptides in plant cells , research-grade purity, industrial yield, low carbon footprint…
Nuance Pharma501-1000 employees
Nuance Pharma are an innovation focused biopharmaceutical company, with both late-stage clinical pipeline and commercial stage asset…
Tolerance BioVenture round $15.1M · 4 mo ago • Founded 2023 • 51-200 employees
Tolerance Bio will increase health span by preserving and restoring the function of the thymus, the master regulator of immune tolerance.

Overview

Puna Bio develops crop biologicals from extremophile microorganisms. Its strains come from high-altitude Argentine environments with harsh conditions. The products help crops grow in degraded and saline soils.

News

News Forbes Argentina 2 months ago
Con más de US$ 10 millones levantados y una proyección para triplicar ventas, así escala al mundo una biotecnológica nacida en el CONICET
Franco Martínez Levis, CEO y cofundador de Puna Bio, junto a las científicas María Eugenia Farías, Elisa Violeta Bertini y Carolina Belfiore, construyeron una empresa que hoy factura más de US$1 millón al año, capta a fondos como Corteva Agriscience y a l
Read more
Report
News Forbes Argentina 2 months ago
De científicas a empresarias: la camada del CONICET que levantó más de US$ 40 millones para fundar startups biotech
Del cáncer a la fertilidad, de los microorganismos de la Puna a los erizos del mar patagónico. Ocho investigadoras formadas en el CONICET convirtieron su ciencia en compañías, traccionaron más de US$ 40 millones de capital y hoy exportan al mundo. Una por
Read more
Report
Press release Nasdaq 1 year ago
Puna Bio receives investment from Corteva Catalyst
--Today Puna Bio announced that it had closed a new round of founding led by Corteva, Inc., through its Corteva Catalyst platform. The new round of funding led by Corteva, Inc., a global pure-play S&P 500 agriculture company, as well as participation from
Read more
Report
News YahooFinance 4 years ago
Puna Bio
The farming industry spends tons of money on artificial means of reinvigorating soil, but an all-natural solution may already exist: beneficial microbes that have evolved to thrive in extreme environments. Puna Bio, which raised a $3.7 million seed round,
Read more
Report

People

Franco Levis
Executive Officer, Director
SEC Form D
Carolina Belfiore
Executive Officer
SEC Form D
Elisa Bertini
Executive Officer, Director
SEC Form D
Maria Farias
Executive Officer
SEC Form D
Laurie Menoud
Director
SEC Form D
Dario Maffei
Director
SEC Form D
Paul Etenberg
Director
SEC Form D
Fred Gruis
Director
SEC Form D
Names and roles come from public filings, company registers and the company's own site. Is this you? Correct or remove · How we handle this data

Offices

Where the company hires and what each office is for
Cities
1
Hiring now
0
Countries
1
Buenos Aires Argentina
HQ
50-200 est. staff

Financials

Total raised
$20.3M
Latest round
Venture - Series Unknown
Funding rounds
1
Funding rounds
Round Announced Amount
Venture - Series Unknown 2025 $20.3M Details